Skip to main content
. 2022 May 30;8(2):00528-2021. doi: 10.1183/23120541.00528-2021

TABLE 5.

Use of various types of medicines in subjects with current wheeze and severe asthma with or without doctor-diagnosed asthma

Current wheezers with doctor-diagnosed asthma Current wheezers without doctor-diagnosed asthma p-value# Severe asthma with doctor-diagnosed asthma Severe asthma without doctor-diagnosed asthma p-value#
6–7-year age group n=115 n=519 n=95 n=225
 Inhaled β-agonists
  Only when needed 41 (35.65) 10 (1.93) 0.000 33 (34.74) 3 (1.33) 0.000
  In short courses 18 (15.65) 5 (0.96) 15 (15.79) 1 (0.44)
  Every day 5 (4.35) 0 (0.0) 3 (3.16) 0 (0.0)
  Not using any medicine 51 (44.35) 504 (97.11) 44 (46.31) 221 (98.23)
 ICS
  Only when needed 16 (13.91) 8 (1.54) 0.000 11 (11.58) 3 (1.33) 0.000
  In short courses 12 (10.43) 1 (0.19) 11 (11.58) 0 (0.0)
  Every day 4 (3.48) 1 (0.19) 3 (3.16) 0 (0.0)
  Not using any medicine 83 (72.18) 509 (98.08) 70 (73.68) 222 (98.67)
 Combined (ICS+LABA)
  Only when needed 14 (12.17) 4 (0.77) 0.000 9 (9.47) 1 (0.44) 0.000
  In short courses 6 (5.22) 3 (0.58) 4 (4.21) 0 (0.0)
  Every day 9 (7.83) 1 (0.19) 8 (8.42) 0 (0.0)
  Not using any medicine 86 (74.78) 511 (98.47) 74 (77.90) 224 (99.56)
13–14-year age group n=239 n=701 n=182 n=380
 Inhaled β-agonists
  Only when needed 107 (44.77) 41 (5.85) 0.000 97 (53.30) 26 (6.84) 0.000
  In short courses 18 (7.53) 22 (3.14) 17 (9.34) 7 (1.84)
  Every day 8 (3.35) 1 (0.14) 7 (3.85) 1 (0.26)
  Not using any medicine 106 (44.35) 637 (90.87) 61 (33.52) 346 (91.06)
 ICS
  Only when needed 30 (12.55) 13 (1.85) 0.000 23 (12.64) 11 (2.89) 0.000
  In short courses 46 (19.25) 6 (0.86) 42 (23.07) 5 (1.32)
  Every day 8 (3.35) 0 (0.0) 5 (2.75) 0 (0.0)
  Not using any medicine 155 (64.85) 682 (97.29) 112 (61.54) 364 (95.79)
 Combined (ICS+LABA)
  Only when needed 65 (27.20) 16 (2.28) 0.000 58 (31.86) 13 (3.42) 0.000
  In short courses 6 (2.51) 4 (0.57) 0.012 4 (2.20) 4 (1.05)
  Every day 5 (2.09) 2 (0.29) 0.005 5 (2.75) 2 (0.53)
  Not using any medicine 163 (68.20) 679 (96.86) 115 (63.19) 361 (95.0)
Adults n=603 n=2077 n=467 n=1032
 Inhaled β-agonists
  Only when needed 218 (36.15) 24 (1.16) 0.000 171 (36.62) 16 (1.55) 0.000
  In short courses 33 (5.47) 4 (0.19) 31 (6.64) 3 (0.29)
  Every day 30 (4.98) 3 (0.14) 26 (5.57) 3 (0.29)
  Not using any medicine 322 (53.40) 2046 (98.51) 239 (51.17) 1010 (97.87)
 ICS
  Only when needed 58 (9.62) 9 (0.43) 0.000 49 (10.49) 7 (0.68) 0.000
  In short courses 21 (3.48) 3 (0.14) 19 (4.07) 3 (0.29)
  Every day 13 (2.16) 0 (0.0) 11 (2.36) 0 (0.0)
  Not using any medicine 511 (84.74) 2065 (99.43) 388 (83.08) 1022 (99.03)
 Combined (ICS+LABA)
  Only when needed 101 (16.75) 11 (0.53) 0.000 73 (15.63) 8 (0.78) 0.000
  In short courses 18 (2.99) 4 (0.19) 14 (3.00) 4 (0.39)
  Every day 37 (6.14) 0 (0.0) 32 (6.85) 0 (0.0)
  Not using any medicine 447 (74.12) 2062 (99.28) 348 (74.52) 1020 (98.83)

Data are presented as n (%), unless otherwise stated. ICS: inhaled corticosteroid; LABA: long-acting β-agonist. #: the Chi-squared test is used when all expected cell frequencies are ≥5. If expected cell frequency was <5 the Fisher exact probability test was used. : severe asthma is defined as current wheeze with more than four attacks per year or wheeze affecting speech or activity.